These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

75 related articles for article (PubMed ID: 4144783)

  • 1. [Ethaverin, a coronary dilator with beta-receptor depressing and antiarrhythmia myocardial effects].
    Fleckenstein A; Grün G; Döring HJ; Haastert HP; Tritthart H
    Med Welt; 1973 Mar; 24(12):441-9. PubMed ID: 4144783
    [No Abstract]   [Full Text] [Related]  

  • 2. Effect of 4-(2-hydroxy-3-isopropylaminopropoxy) acetanilide (AY 21,011) on the myocardial and coronary vascular responses to adrenergic stimulation.
    Lucchesi BR; Hodgeman RJ
    J Pharmacol Exp Ther; 1971 Jan; 176(1):200-11. PubMed ID: 4398216
    [No Abstract]   [Full Text] [Related]  

  • 3. [Comparative studies on the characterization of the beta-receptor stimulating properties of tetrahydropapaverolin].
    Rohte O; Ochlich P
    Dtsch Tierarztl Wochenschr; 1976 May; 83(5):178-88. PubMed ID: 6239
    [No Abstract]   [Full Text] [Related]  

  • 4. The influence of pharmacological blockade of presynaptic and postsynaptic adrenergic structures on electrically induced arrhythmias of the guinea-pig atria.
    Grodzińska L
    Folia Biol (Krakow); 1969; 17(4):347-55. PubMed ID: 4392109
    [No Abstract]   [Full Text] [Related]  

  • 5. [Modification of the cardiostimulatory and coronary dilator effect of isopreenaline caused by etafenone].
    Kukovetz WR
    Arzneimittelforschung; 1975 Jan; 25(1):31-8. PubMed ID: 238542
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Analysis of cardiac beta-receptors. Studies by means of dose-effect-curves of isoprenaline, propranolol and KL 255].
    Holtermann W; Lochner W
    Arzneimittelforschung; 1970 Jan; 20(1):8-12. PubMed ID: 4392501
    [No Abstract]   [Full Text] [Related]  

  • 7. Effect of o-2-hydroxy-3-(tert.-butylamino) propoxybenzonitrile HCl (KO 1366) on beta adrenergic receptors in the cardiovascular system.
    Nayler WG; Tay J
    J Pharmacol Exp Ther; 1972 Feb; 180(2):302-16. PubMed ID: 4400889
    [No Abstract]   [Full Text] [Related]  

  • 8. Effects of a cardio-selective beta-adrenergic blocking agent on the heart and coronary circulation.
    Ross G; Jorgensen CR
    Cardiovasc Res; 1970 Apr; 4(2):148-53. PubMed ID: 4392942
    [No Abstract]   [Full Text] [Related]  

  • 9. Cardiac pharmacology.
    Mendez R; Kabela E
    Annu Rev Pharmacol; 1970; 10():291-312. PubMed ID: 4392812
    [No Abstract]   [Full Text] [Related]  

  • 10. [Pharmacological studies with 1-isopropylamino-3-(o-allyloxyphenoxy)-2-propanol-hydrochloride, an adrenergic beta-receptor blocking agent].
    Brunner H; Hedwall PR; Meier M
    Arzneimittelforschung; 1968 Feb; 18(2):164-70. PubMed ID: 5695373
    [No Abstract]   [Full Text] [Related]  

  • 11. Verapamil in cardiology.
    Krikler D
    Eur J Cardiol; 1974 Aug; 2(1):3-10. PubMed ID: 4153535
    [No Abstract]   [Full Text] [Related]  

  • 12. Myocardial effects of phentolamine.
    Das PK; Parratt JR
    Br J Pharmacol; 1970 Sep; 40(1):150P-151P. PubMed ID: 4395081
    [No Abstract]   [Full Text] [Related]  

  • 13. Cardiovascular and antiarrhythmic effects of 1-(4,5-dichloro-2-thienyl)-2-t-butylaminoethanol (QM-5119), a new beta-adrenergic blocking agent.
    Darias V; del Río J
    Arzneimittelforschung; 1974 Nov; 24(11):1756-9. PubMed ID: 4155633
    [No Abstract]   [Full Text] [Related]  

  • 14. Pharmacology of a new beta-adrenoceptor blocking agent, The 15219.
    Caputi AP; Marmo E; Saini RK
    Res Commun Chem Pathol Pharmacol; 1972 Jul; 4(1):25-35. PubMed ID: 4152996
    [No Abstract]   [Full Text] [Related]  

  • 15. Effects of oxprenolol on cardiac contractile force, heart rate and coronary circulation.
    Meier M
    Postgrad Med J; 1970 Nov; ():Suppl:15-21. PubMed ID: 4395454
    [No Abstract]   [Full Text] [Related]  

  • 16. [The influence of long term dipyridamole application on the coronary flow and isoproterenol and papaverine effects on the isolated hearts of small mammals].
    Mentz P; Förster W; Wartner U
    Arch Int Pharmacodyn Ther; 1973 Dec; 206(2):317-24. PubMed ID: 4778622
    [No Abstract]   [Full Text] [Related]  

  • 17. Pharmacological actions of 1-(o-methoxyphenoxy)3-isopropylamino-2-propanol hydrochloride (S-D-1601), a new beta-blocking agent.
    Ferrini R; Miragoli G; Croce G
    Arzneimittelforschung; 1970 Aug; 20(8):1074-9. PubMed ID: 4394830
    [No Abstract]   [Full Text] [Related]  

  • 18. Cardiovascular pharmacology of two new beta-adrenergic receptor antagonists.
    Stanton HC; Kirchgessner T; Parmenter K
    J Pharmacol Exp Ther; 1965 Aug; 149(2):174-82. PubMed ID: 4378559
    [No Abstract]   [Full Text] [Related]  

  • 19. [Effect of some sympathomimetic amines on the coronary resistance in the dog heart in situ during heart beat and asystole].
    Bassenge E; Doutheil U
    Arzneimittelforschung; 1970 Mar; 20(3):343-7. PubMed ID: 4392592
    [No Abstract]   [Full Text] [Related]  

  • 20. Coronary and myocardial effects of dopamine in the conscious dog: parasympatholytic augmentation of pressor and inotropic actions.
    Vatner SF; Millard RW; Higgins CB
    J Pharmacol Exp Ther; 1973 Nov; 187(2):280-95. PubMed ID: 4147854
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.